Population-based analysis reveals increased stimulant prescriptions during the pandemic, suggesting urgent monitoring needs.
In Ontario, rates of new prescriptions for stimulants dispensed to adults accelerated rapidly during the COVID-19 pandemic. Monitoring and evaluation are needed to ensure appropriateness of use and safeguard against potential harms.
No takes yet. Share an insight, caveat, or question.
Gomes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: